# PHYSIOLOGIC AND RELATED BEHAVIORAL OUTCOMES FROM THE WOMEN'S
 LIFESTYLE HEART TRIAL 1,2

## Deborah J. Toobert, Ph.D. and Russell E. Glasgow, Ph.D.

Oregon Research Institute

## Janice L. Radcliffe, Ph.D.

University of Oregon

ABSTRACT 236,574 deaths in females and approximately 197,680 (75%)

mortalities per year among postmenopausal females (2,3). Exclu-

_The Women's Lifestyle Heart Trial was a small (N = 28)_

sion of females, especially older women, from CHD research has

_randomized controlled trial to evaluate the effects of a comprehen-_

been commonplace (4). Relatively little research has focused on

_sive lifestyle self-management program (very low-fat vegetarian_

strategies to promote healthier lifestyles for women with CHD (5).

_diet, stress-management training, exercise, group support, and_

Of the reports on treatment of CHD that have included women,

_smoking cessation) on reduction of cardiovascular risk factors in_
_postmenopausal women with coronary heart disease (CHD)._ most have focused on drug therapy and invasive interventions such

_Women assigned to the treatment condition (Prime Time) partici-_ as coronary bypass surgery or coronary angioplasty (6). Resource
_pated in a week-long retreat followed by twice-weekly 4-hour_ intensive technologies such as coronary bypass surgery have
_meetings. Endpoints were program adherence; changes in lipid_ become focal points for the debate over cost control and adequate
_profiles, body mass, blood pressure, hypolipidemic and antihyper-_ access to health care (7). Strategies to promote healthier lifestyles

_tensive medications; and quality of life. Risk factor and psychoso-_ for health care consumers--as opposed to surgical or medical
_cial evaluations were conducted at baseline and at 4, 12, and 24_ procedures--may ultimately reduce the use of medical services
_months. Repeated measures analyses of covariance revealed that_ and help to contain costs, as well as prevent initial or recurrent
_the dietary, stress management, and physical activity changes_ heart attacks (8).
_made by intervention women were dramatic and lasting. There_ There is convincing evidence that improvements in lifestyle
_were significantly greater improvements in the Prime Time condi-_

behaviors, which include smoking cessation (9), diet (10), exercise

_tion compared to the usual care control group on body mass,_

(11), and stress management (12,13), can reduce further heart

_angina symptoms, and quality of life, and a tendency for a greater_

disease problems. However, it is clear that an individual's risk for

_reduction in blood pressure-lowering medications. Similar pat-_

developing heart disease is not a result of one risk factor in

_terns were seen in lipids, blood pressure, and lipid-lowering_

isolation, but rather a product of a complex set of risk factors, and

_medications, but did not reach significance. These results demon-_

the contribution of each to overall risk varies from person to person

_strate that postmenopausal CHD women can make lasting lifestyle_

(14,15). While available data strongly implicate the contribution of

_changes, and that these changes may reduce the need for cardiac_

these risk factors to heart disease, investigations aimed at interven-

_medications and improve CHD risk factors and quality of life._

ing simultaneously on combinations of factors are practically

## (Ann Behav Med 2000, 22 (1): 1-9) nonexistent (13,16-18).

Few investigators (19-23) have studied a comprehensive

INTRODUCTION lifestyle program for treating CHD. Compared to their control

Coronary heart disease (CI-ID) is the leading cause of death group counterparts, patients participating in these studies have
among women in the United States (1). In 1990, it accounted for generally had slower rates of progression, and even regression, of

coronary lesions. Ornish et al. (24) performed a prospective
randomized controlled trial of multiple lifestyle changes versus

Preparation of this manuscript was supported in part by grant R29 usual care in patients with clinically manifest coronary disease.
HL50181 from the National Heart, Lung, and Blood Institute. The Comprehensive Lifestyle Program (CLP) consisted of a very

2 The authors thank Linda Nettekoven and Jane Brown for their compas- low-fat diet, smoking cessation, stress-management training, mod-
sion and dedication and Bonnie LaMont for her devotion and soothing erate aerobic exercise, and group support. Of 48 patients random-
stress-management sessions; Drs. Greg Brown, Sandra McClanahan, Dean

ized to experimental or control groups, 41 had undergone repeat

Ornish, and Larry Seherwitz for their assistance during the development

coronary arteriography at Year 1. Their average percent diameter

and intervention phases of this project; Dr. Jim Billings, Melanie Elliot,
Lee Lipsenthal, Amy Gage, and Lawrence Spann for their support and stenosis regressed from 40.0% to 37.8% in the experimental group
therapy sessions with project staff during the 2 �89 trial; Lisa Strycker and progressed from 42.7% to 46.1% in the control group
for editorial contributions to the manuscript; John Koenig, Rachel

(p < 0.001).

Sheuring, Dr. Brad Roy, Dr. Matthew Riddle, Jodie Donnelly, and Hank

The purpose of the PrimeTime program was to develop and

and Phyllis Ginsberg for their generous donations of time during the retreat
and at the weekly meetings; and especially, the PrimeTime women for their evaluate an intervention to improve self-care and reduce secondary
courage and spirit throughout the study. CHD risk among postmenopausal CHD women, using the proce-

_Reprint Address:_ D. J. Toobert, Ph.D., Chronic Illness Research Group, dures developed by Ornish (13,25) for the Lifestyle Heart Trial.
Oregon Research Institute, 1715 Franklin Boulevard, Eugene, OR This report presents the effects of the PrimeTime program on
97403-1983.

lowering cardiovascular risk factors and improving quality of life

�9 2000 by The Society of Behavioral Medicine. in these women.


-----

## METHODS and (d) small group discussions similar to those held during the Study Design and Participants retreat.

PrimeTime participants were instructed to adhere to the

The PrimeTime program was promoted extensively among

Reversal Diet (13), which contains no animal products other than

local physicians and through presentations, mailings, individual

egg whites and nonfat yogurt and no added oils or other concen-

meetings, and the local media. Persons interested in the project

trated fats. The high-fiber diet contains less than 10% of calories

called to receive a description of the project and to determine

from fat, 70% to 75% of calories from carbohydrates, 15% to 20%

eligibility. Eligibility requirements included being a postmeno-

of calories from protein, and 5 milligrams of cholesterol per day.

pansal female and having documented CHD defined as atheroscle-

After 15 months, the twice-weekly group meetings were reduced

rosis, myocardial infarction (MI), percutaneous transluminal coro-

to 2-week intervals for 6 months, then reduced to once per month

nary angioplasty, and/or coronary bypass graft surgery. Exclusion

for the final 3 months.

criteria employed by Ornish et al. (24,25), including having other
life-threatening illnesses, infarction during the preceding 6 weeks,
receiving streptokinase or alteplase, or being scheduled for bypass **Measures**
surgery, were used. CHD documentation and permission from A demographic/medical history questionnaire was adminis-
one's primary care physician and cardiologist were required. tered in which participants identified the presence or absence of 15
Participants completing baseline assessment (75% of those express- comorbidities. The behavioral measures have been previously
ing interest and eligible) were stratified and then randomized to described (23). Dietary measures consisted of the Kristal Food
either the PrimeTime program or to usual care (UC). Stratification Habits Questionnaire (FHQ) (26), a 4-day food record (27), and a
was by: (a) total/HDL cholesterol ratios of greater than versus less paper-and-pencil dietary fat intake screener (28). The FHQ, a
than 6.0, (b) smoking status, and (c) presence or absence of 20-item questionnaire, was employed to measure behaviors associ-
diabetes. Since these are major risk factors for CHD in women and ated with eating low-fat foods. Participants' 4-day food records
given the small sample size, we anticipated that a predominance of were scored to determine average daily percent of calories
one of these risk factors in either the treatment or control group consumed from fat and saturated fat, using the Minnesota Nutrition
could overpower the effects of the intervention. Participants were Data System (NDS) software (29). The fat screener (28) provided
assessed at baseline and at 4, 12, and 24 months. an estimate of daily grams of fat.

Exercise measures consisted of the Stanford 7-Day Recall
(30), which provided average kilocalories expended per day, and a

## PrimeTime Intervention composite score from our Summary of Self-Care Activities

Participants randomized to the PrimeTime program began the Questionnaire (31).
intervention with a 7-day retreat (24). Each woman was encour- Stress-management activities were assessed using the Sum-
aged to bring her spouse or a support partner who had agreed to mary of Self-Care Activities Questionnaire (31).
assist her in carrying out the program. The daily schedule for the Current medications, including antihypertensive and hypolip-
retreat included cooking classes, and meals were planned by the idemic medications, a reflection of physiological outcomes, were
project dietician to follow the Reversal Diet (13) guidelines (e.g. obtained by interview.
vegetarian, less than 10% calories from fat). Serum lipid profiles (mg/dl), blood pressure, and body mass

Study participants received instruction in, and had an opportu- index (BMI) were the physiological endpoints to document
nity to practice, stress-management techniques twice per day changes in CHD risk. The serum lipid profile was measured once at
during the retreat led by a certified Yoga instructor. The stress- each endpoint to contain costs and lessen the demand on the
management techniques included Hatha Yoga stretches, progres- participant's time. Fasting plasma total cholesterol (TC), high-
sive deep relaxation, deep breathing, meditation, and directed or density lipoprotein cholesterol (HDL-C), and triglycerides (Tg)
receptive imagery (i.e. visualizing improvements occurring in the were measured directly, and low-density lipoprotein cholesterol
heart). The women were asked to practice these techniques 1 hour (LDL-C) was calculated using the formula: LDL-C = TC -
per day and were given audiocassette tapes to assist them. (TG/5 + HDL-C). The Colin STBP-680 automated blood pressure

Daily group physical activity sessions included warm-up, unit was used to determine resting blood pressure, using the
walking or aerobics, and a cool-down led by an American College Heritage protocol (32). An average of six valid blood pressure
of Sports Medicine certified exercise physiologist. Participants readings was used for analyses.
were individually prescribed exercise intensity based on their A measure of weight (kg) was taken in the morning in the
treadmill exercise test performance. Following the retreat, the fasting state, in stocking feet on a calibrated Cardinal Detecto
intervention exercise program required participants to engage in a Electronics digital readout scale. The scale, which has a capacity of

## 1-hour session per day at least 3 days each week. 400 pounds (by 2 graduation values), is accurate to plus or minus 1

Retreat evenings ended with small, relatively unstructured graduation. The scale was situated on a tile floor. Height, measured
group sessions for sharing feelings. Participants discussed difficul- using a height bar attached to the scale and with participants
ties with program components and emotional issues as they arose, standing without shoes and with head straight, was rounded to the
practiced communication skills, and engaged in exercises to build nearest 0.5 cm. Measurements were converted to BMI (kg/m2).
group support and decrease feelings of social isolation. Group Frequency, duration, and severity of angina were reported using
leaders emphasized unconditional positive regard and encouraged the Rose Chest Pain Questionnaire (33). Also calculated was a
participants to share feelings rather than thoughts and to refrain Framingham Heart Study (34) score for CHD women, which
from offering advice. corresponds with an estimated percent risk of having another heart

Twice-weekly 4-hour meetings followed the retreat. Each attack, stroke, or death from CI-ID in the next 2 years. This score
meeting followed a sequence similar to the retreat schedule: (a) calculates heart disease risk in terms of age, HDL cholesterol,
supervised exercise training, (b) Yoga and relaxation led by a systolic blood **pressure, cigarette smoking, and presence or ab-**


-----

A general measure of functioning, the Medical Outcomes **TABLE 1**
Study (MOS) Short-Form General Health Survey (SF-36) (35) was **Baseline Comparisons of the Usual Care Versus the PrimeTime**
administered to assess quality of life. **Participants**

PT UC

**Statistical Analyses**

(n = 14) (n = 11)

A series of one-way analyses of variance (ANOVA) were Mean (SD) Mean (SD) Signifi-
conducted to evaluate baseline equivalence of conditions and Patient Characteristic or n or n cance*
subject attrition. Given the small sample size and large number of

Years diagnosed with CHD, mean

measures, multivariate analyses of covariance (MANCOVA) were

_(SD)_ 11 (10) 12 (10) .92

used to control experiment-wide error rate in evaluating program Clinical characteristics
outcomes. MANCOVAs were conducted to evaluate intervention Coronary angiographic indica-
effects on three behavioral components (PrimeTime program tion of disease progression, n 7 6 .74
adherence to dietary, physical activity, and stress management) and Previous acute myocardial infarc-
serum lipids (cholesterol, LDL, HDL, and triglycerides). Where tion, n 7 6 .83
the overall MANCOVA was significant, follow-up analyses of Percutaneous transluminal coro-

nary angioplasty, n 5 4 .98

covariance (ANCOVAs) were conducted to identify variables

Coronary artery bypass graft sur-

accounting for the differential change. In all analyses, baseline

gery, n 3 4 .43

scores on the dependent variable, the Social Desirable Respond-

Average number of comorbidities,

ing Scale (36) (for psychosocial measures), and number of

_mean (SD)_ 2.6 (1.7) 4.1 (1.9) .03

comorbid chronic diseases served as covariates. The MANCOVAs Presence of diabetes, n 5 6 .37
were repeated on data collected at the 4-, 12-, and 24-month Age, mean (SD) 64 (10) 63 (11) .80
assessments. Medications, n

Lipid-lowering 4 5 .65
Blood pressure-lowering 10 9 .73

**RESULTS**

Estrogen replacement therapy 5 5 .64

Twenty-eight participants who completed baseline assess-

Marital status, n

ments were randomized into the study. After the retreat, three

**Married** 9 8 .67

PrimeTime participants were lost to follow-up. Of those, two Divorced/single 1 1 .87
experienced discomfort with the program and one died of an acute Widowed 4 2 .57
myocardial infarction prior to the 12-month follow-up. Twenty- Having a partner to attend program, n 11 7 .35
five participants completed the 24-month follow-up. Present living arrangement, n

The baseline sample reported here is comprised of the 25 With spouse 7 7 .52
participants who completed the 24-month follow-up. As can be With spouse and children 2 1 .71

With children 1 1 .87

seen in Table 1, no differences between conditions were found on

Alone 4 2 .57

any of the demographic and medical history variables with the

Level of education achieved, n .17

exception of number of comorbid chronic diseases. Most patients

7th to llth grade 0 2

had lived with their heart disease for a number of years, and 97% of High school graduate 4 3
the baseline sample also had other chronic diseases, most com- Partial college 7 5
monly arthritis, hypertension (each affecting 68% of subjects), and College/University graduate 3 1
diabetes (44%). The UC group had an average of 4.1 comorbid Ethnicity, n .57
chronic illnesses and the PrimeTime group had an average of 2.6 White, not Latino 13 10
(F = 5.1, p < .02). The mean age was 63 with 32% of participants Lafino 0 1

Native American or Alaskan 1 0

older than 70 years of age. Thirty-six percent of the participants

Glycosylated hemoglobin, mean %

were treated with cholesterol-lowering medication at baseline, and

_(SD)_ 6.3 (1.4) 6.6 (1.4) .67

40% were receiving hormone replacement therapy.

Weight, mean kg (SD) 80 (10) 79 (15) .83
Body mass index, mean kg/m 2 (SD) 32 (4.2) 32 (5.5) .98

**Program Adherence** Waist/hip ratio, mean (SD) .91 (.1) .92(.1) .83

_Attendance:_ Attendance at the twice-weekly 4-hour meetings Systolic blood pressure, mean mm
for the duration of the 15-month treatment phase was good, with Hg (SD) 145 (21) 142 (21) .70

Diastolic blood pressure, mean mm

PrimeTime women attending an average 81% and support partners

Hg (SD) 78 (11) 70 (10) .64

attending an average 70% of the sessions (SD = 13; range = 64 to

Total cholesterol, mean mg/dl (SD)** 233 (39) 234 (54) .95

104 of 118 total). During the maintenance phase, attendance for

LDL cholesterol, mean mg/dl

PrimeTime women at the 16 sessions ranged from 1 to 16 sessions

_(SD)**_ 147.9 (35.1) 137.3 (34.4) .50

(Mean = 10). HDL cholesterol, mean mg/dl

_(SD)**_ 40.3 (13.5) 41.0 (13.6) .90

_Behavioral Outcomes:_ A series of three multivariate repeated

Plasma triglycerides, mean mg/dl

measures analyses of covariance were conducted to evaluate the

_(SD)**_ 227.3 (115.5) 346.6 (321.3) .21

intervention effects on the following sets of measures: (a) dietary Ratio of total to HDL cholesterol,
behavior, (b) physical activity, and (c) stress management. As _mean (SD)_ 6.3 (2.3) 6.2 (2.3) .90
shown in Table 2, the PrimeTime group showed significantly

                                           - Significance of one-way analysis of variance (ANOVA) comparing

greater improvement on percent of dietary total and saturated fat

treatment and control at baseline.

than did the UC group, but not on total caloric intake. Data from ** To convert values for cholesterol to millimoles per liter, multiply by


-----

TABLE 2
**Behavioral Outcome Results**

Significance of
Baseline 4 Months 12 Months 24 Months MANCOVA*

or Follow-up

Measure Condition Mean (SD) Mean (SD) Mean (SD) Mean (SD) ANCOVA

Dietary fat F = 15.8; p = .000
Percent calories from fat PT 25 (10) 11 (3) 13 (7) 12 (6) p < .000
UC 29 (8) 26 (9) 27 (8) 28 (9)
Percent calories saturated fat PT 7.8 (4.1) 2.7 (.9) 3.7 (2.4) 3.1 (2.4) p < .000
UC 9.5 (3.3) 8.2 (3.0) 8.7 (3.3) 8.7 (3.0)
Caloric intake F = 1.01; p = .164
Mean total caloric intake PT 1664 (422) 1340 (285) 1480 (489) 1349 (284)
UC 1358 (253) 1263 (321) 1362 (408) 1394 (477)
Physical activity F = 8.00; p = .005
Summary of self-care PT 3.9 (1.8) 4.8 (1.0) 4.6 (1.5) 3.7 (2.0)
UC 2.3 (1.5) 2.5 (1.1) 2.5 (1.7) 2.7 (1.6)
Stress management F = 6.12; p < .005
Structured interview PT 2.8 (2.6) 5.8 (2.1) 5.4 (2.1) 5.4 (2.2) p = .000
UC 2.8 (2.7) 3.3 (2.6) 1.5 (2.0) 2.8 (2.4)
Summary of self-care PT 1.5 (1.8) 4.6 (1.6) 3.6 (1.8) 3.0 (1.9) p = .04
UC 1.4 (1.7) 3.1 (1.9) 2.6 (1.9) 2.9 (1.6)

        - Significance of one-tailed repeated measures multivariate analysis of covariance (MANCOVA) comparing the PT and UC follow-up scores, controlling
for baseline scores. When overall MANCOVA is significant, follow-up ANCOVA results are provided.

**TABLE 3**
**Levels of Antihypertensive and Lipid-Lowering Medications by Condition Over Time**

Assessments Significance of ANCOVA*

Baseline 4 Month 12 Month 24 Months Individual Time Points

Measure Mean (SD) Mean (SD) Mean (SD) Mean (SD) 4 Months 12 Months 24 Months

Antihypertensive medications (mg) F = 3.56; p = .037
PT 97 (121) 21 (77) 75 (161) 92 (207) .016 .089 .083
UC 120 (115) 240 (345) 236 (374) 262 (354)
Lipid lowering medications (mg) F = 2.19; p = .077
PT 95 (318) 43 (160) 91 (325) 101 (340) .054 .070 .140
UC 175 (539) 282 (617) 317 (607) 126 (357)

        - Significance of one-tailed analyses of covariance (ANCOVA), using baseline level of medication as covariate, comparing treatment and control groups.

significant, and consistent improvements in mean percent calories program. This was confirmed by carbon monoxide and saliva
from fat (24-month follow-up scores of 12% for PrimeTime versus continine analyses. The one smoker in the UC group has continued
28% for UC) and mean percent calories from saturated fat to smoke.
(24-month follow-up scores of 3.1% for PrimeTime versus 8.7%
for UC). Improvements were most substantial at the 4-month **Medication Changes**
assessment. Antihypertensive drugs were substantially reduced in the

Physical activity results parallel those reported above for PrimeTime women from baseline to the 4-month follow-up (from
dietary self-care. There was a significant overall effect on the 97 mg per person per day on average to 21 mg per person per day),
repeated measures MANCOVA for physical activity (F = 8.0; compared to a substantial increase among the UC condition (120
p = .01). PrimeTime participants substantially increased their mg at baseline to 240 mg at 4-month follow-up). The repeated

number of exercise sessions and number of minutes spent engaged measures ANCOVA on change in medication from baseline was
in physical activity each day compared to the UC group. significant (F = 3.56; p = .037). The PrimeTime women main-

Stress-management results indicated the PrimeTime group tained some of their improvement at the 12- and 24-month
significantly increased the number of times per week they engaged follow-ups (see Table 3).
in stress-management activities compared to the UC condition (see At baseline, the UC group was taking an average 175 mg of
Table 2). These increases were detected by both the Structured lipid medications, compared to an average 95 mg in the PrimeTime
Interview and the Summary of Self-Care Questionnaire. The condition. At the 4-month follow-up, the PrimeTime women were
PrimeTime participants showed a slight, nonsignificant decrease in taking an average of 52 mg less than they had at baseline, while the
practice of stress-management techniques at the 12- and 24-month UC group had increased an average of 107 mg (p = .054). The
follow-ups. repeated measures ANCOVA revealed that the PrimeTime women

The one smoker in the PrimeTime group successfully quit did not maintain these improvements at the 24-month follow-up


-----

**TABLE 4**
**Changes in Physiologic Risk Factors**

Assessements

Baseline 4 Months 12 Months 24 Months
Significance of
Measure Mean (SD) Mean (SD) Mean (SD) Mean (SD) MANCOVA*

Serum lipids F = 1.34; p = .13
Total cholesterol

PT 233 (39) 242 (40) 227 (36) 224 (32) p = .257
UC 234 (54) 255 (92) 288 (275) 213 (63)
LDL cholesterol

PT 156 (30) 155 (31) 137 (21) 137 (19) p = .477
UC 138 (32) 138 (32) 127 (32) 131 (51)
HDL cholesterol

PT 40 (14) 39 (11) 40 (11) 43 (13) p = .343
UC 41 (14) 40 (10) 40 (11) 40 (9)
Triglycerides

PT 227 (116) 262 (112) 254 (111) 233 (106) p = .378
UC 347 (321) 456 (514) 284 (191) 263 (210)
Total/HDL cholesterol F = 2.14; p = .080
PT 6.1 (2.1) 6.5 (1.8) 6.1 (1.7) 5.9 (2.6)
UC 5.9 (2.1) 6.1 (2.0) 5.3 (1.6) 5.2 (1.5)
Body mass index F = 3.34; p = .041
PT 32 (4) 30 (3) 30 (4) 31 (4)
UC 32 (6) 32 (6) 32 (6) 32 (6)
Blood pressure Overall F = .89, p = .213
Systolic

PT 142 (21) 140 (21) 145 (20) 135 (22) p = .081
UC 145 (21) 149 (17) 151 (23) 147 (28)
Diastolic

PT 70 (10) 66 (12) 68 (13) 64 (15) p = .239
UC 72 (7) 71 (8) 71 (10) 67 (15)
Chest pain frequency (episodes)

PT 2.5 (3.6) .77 (1.1) .50 (1.1) .39 (.51) F = 6.68;p = .01
UC 2.8 (3.2) 2.3 (2.8) .90 (1.1) 3.0 (5.5)
Chest pain duration (minutes)

PT 9.7 (10.9) 14.6 (27.7) 3.4 (4.8) 3.0 (5.5) F = 2.72; p = .06
UC 6.0 (2.8) 9.2 (8.7) 7.0 (7.0) 10.1 (12.4)
Chest pain severity (1-7 scale)

PT .85 (1.6) 2.1 (2.0) 1.6 (1.7) 1.2 (1.6) F = .81;p = .19
UC 1.6 (1.7) 2.5 (2.2) 2.3 (2.1) 2.6 (2.2)
Framingham risk score

PT 12.06 (6.1% risk) 12.25 (6.6% risk) 11.36 (6.0% risk) 10.86 (4.9% risk) F = 2.8; p = .055
UC 11.63 (6.1% risk) 11.8 (6.3% risk) 12.0 (5.9% risk) 11.9 (6.5% risk)

       - Significance of one-tailed repeated measures multivariate analyses of covariance (MANCOVA) comparing treatment and control follow-up scores
covarying the effect of baseline scores.

**Physiologic Outcomes** the PrimeTime women, but did not reach statistical significance

Some favorable changes in risk factor status occurred for (see Table 4).
women in the PrimeTime condition. These results are summarized The PrimeTime women improved their heart disease risk
in Table 4. There was a small but significant decrease in BMI in score over the course of the 2 years. Their risk of further heart
PrimeTime women compared to UC (p = .041). The repeated disease, stroke, or cardiovascular death decreased from 12.06
measures ANCOVA revealed a 2-point drop in BMI from baseline (6.1% risk) at baseline to 10.86 (4.9% risk) (p = .04) at 24
to the 4- and 12-month follow-ups in the PrimeTime women, with months, while that of the control group rose from 11.63 (6.1%) to
no change for the UC group. The PrimeTime women gained 1 11.9 (6.5%) during the same period. The repeated measures
point in BMI at 24-month follow-up. ANCOVA comparing conditions was marginally significant

On the Rose questionnaire (33), PrimeTime women reported a (p = .055).
reduction in frequency of chest pain episodes in the past 7 days Differences between the PrimeTime and UC conditions in
from an average of 2.5 at baseline to 0.4 at the 24-month follow-up. average changes in plasma lipid concentrations and blood pressure
The frequency of chest pain episodes rose over the 2-year period did not achieve statistical significance (see Table 4).
for the UC group from an average of 2.8 at baseline to 3.0 at 24 While the PrimeTime group made impressive improvements
months (repeated measures ANCOVA, F = 6.68; p = .01). Dura- in dietary fat intake, it is interesting to examine how closely they


-----

**TABLE 5**
**Comparison of Guidelines and Actual Results: Ornish Lifestyle Heart Trial versus Women's Lifestyle Heart Trial**

Actual Results

Women's Lifestyle Heart Trial

Ornish Ornish at Months after Baseline
Program Requirement Guidelines 12 Months 0 4 12 24

Calories from fat (%) 10% 6.8% 25% 11% 13% 12%
Polyunsaturated/saturated fat ratio Greater than 1 Not available .76 1.4 1.2 1.2
Calories from protein (%) 15%-20% Not available 18 % 16% 16% 16%
Calories from complex carbohydrates (%) 70%-75% Not available 57% 76% 74% 75%
Dietary cholesterol (rag/day) 5 12.4 174 27 34 41
Stress management (times/week) 7 5.94 .43 .71 .71 .71
Technique practice (minutes/day) 60 82.1 N/A N/A N/A N/A
Physical activity (minutes/week) 120 184 34 172 188 144

shown in Table 5, the group approached, but did not on average participants, adherence and participation levels were good, and the
meet, the recommended Ornish guidelines or the levels reported of intervention was moderately effective in producing improvements
his study participants. in BMI, angina symptoms, use of antihypertensive and lipid-

Given the discrepancies between the Ornish guidelines and lowering medications, coronary risk, and quality of life.
the PrimeTime women's program achievements, how did the It is worth noting that in the Orrtish Lifestyle Heart Trial, total
PrimeTime women fare in terms of changes in CHD risk factors? cholesterol and LDL cholesterol improved significantly, while
Table 6 compares key risk factors between the two programs for triglyceride and HDL cholesterol levels did not. Significant serum
baseline and 12-month follow-up. lipid improvements did not accrue in the Women's Lifestyle Heart

Trial, but both studies achieved significant reductions in body

**Quality of Life**

weight (a l0 kg reduction in the Ornish program versus a 3.9 kg

The repeated measures MANCOVA for all quality of life

reduction in the PrimeTime program). Given their significant

dimensions revealed overalI improvement in favor of the Prime-

dietary improvements, especiaiIy compared to nationai averages

Time participants (F ~ 4.28; p = .026). Follow-up analyses re-

(39), it remains unclear why the PrimeTime women did not show

vealed significantIy greater improvements in quality of life in the

significant improvements in lipids. Gender differences, the small

areas of general health (PrimeTime condition improved an average

sample size, lack of precision in serum lipid measurements, or

4 points, while the UC condition decreased 23 points) and social

perhaps the reduction in their lipid-lowering medication may

functioning (PrimeTime condition improved an average 22 points,

explain this. In the Lyon heart study (40), reduction in coronary

while the UC condition decreased 4 points). The other four scales

events and reduction in cardiac deaths of close to 70% were

of the MOS SF-36 were nonsignificant.

achieved using the Mediterranean diet, without a reduction of total

**Impact of Attrition** cholesterol or triglycerides, or an increase in HDL-C compared to

controls. The Mediterranean diet, rich in carbohydrates and fiber,

The results were reanalyzed to include women who dropped

does not restrict dietary fat as severely as the Ornish diet, but does

out of the study after the retreat. For each construct tested, baseline

restrict saturated fat, which recently has been shown to reduce

scores were substituted for the missing 4-, 12-, and 24-month

incidence of CHD (41).

follow-ups. The analyses made very little difference in the final

Although PrimeTime participants engaged in stress-manage-

outcomes. Of the 13 variables tested, differences on two outcomes

ment activities to a much greater degree than did the UC group,

were positively affected and one outcome was adversely affected.

there is a large discrepancy in the frequency of their practices

Significance levels improved for between-condition differences on
the ratio of total cholesterol to HDL cholesterol (from p = .080 to compared to their male counterparts in the Ornish Lifestyle Heart
p = .033) and for Chest Pain Duration (from p = .06 to p = .05), Trial. Regularly practicing stress-reduction techniques appeared to

and caused one variable, Chest Pain Frequency, to become be challenging for the women. There were many difficulties cited
nonsignificant. by the PrimeTime participants, mostly stemming from structural

problems with their bodies, other chronic diseases, and the feeling

**DISCUSSION** they lacked the time to relax.
The Lifestyle Heart Trial (25), the St. Thomas' Atherosclero- The PrimeTime women appeared to engage in physical
sis Regression Study (37), the Heidelberg Study (38), the Leiden activity on average about 44 minutes less at 24 months compared
Intervention Trial (39), and the Stanford Coronary Risk Interven- to 12 months. The reduction in physical activity by the PrimeTime
tion Project (21) have demoustrated that lifestyle can have a major women at the 24-mouth follow-up may reflect their greatly reduced
influence on progression of coronary artery atherosclerosis. How- contact with the program (from twice per week to once per month)
ever, participants in these trials were primarily male or included by the end. It is possible that group support for exercise is
too few women to allow detection of gender effects. The Women's extremely important. The PrimeTtme women also engaged in less
Lifestyle Heart Trial, despite a small sample size, demonstrated physical activity than the **men in** the Omish study. This is not
that a lifestyle intervention could produce marked, consistent surprising since, compared to men, fewer women enroll in cardiac
behavioral differences sustained over 2 years in postmenopansal rehabilitation programs (42,43). In an assessment study of self-


-----

**TABLE 6**
**Changes in Risk Factors: PrimeTime Program versus Ornish Lifestyle Heart Trial**

Baseline Assessment 12-Month Assessment

Experiment Control Experiment Control

Measure Mean (SD) Mean (SD) Mean (SD) Mean (SD) Significance*

Serum lipids (mg/dl)**

Total cholesterol

PrimeTime 233 (39) 234 (54) 227 (36) 288 (275) .195
Ornish 277 (50) 245 (39) 172 (44) 232 (60) .019
LDL cholesterol

PrimeTime 155 (27) 137 (34) 137 (25) 127 (32) .409
Omish 152 (48) 167 (30) 95 (60) 157 (45) .007
HDL cholesterol

PrimeTime 40 (14) 41 (14) 40 (11) 40 (14) .495
Ornish 39 (10) 52 (20) 38 (15) 51 (15) .832
Triglycerides

PrimeTime 227 (116) 347 (321) 254 (111) 284 (191) .237
Ornish 211 (112) 217 (219) 258 (130) 198 (159) .247
Lipid ratios

Total/HDL

PrimeTime 6.34 (2.28) 5.89 (2.10) 6.06 (1.66) 5.31 (1.59) .151
Ornish 6.33 (2.14) 5.32 (1.89) 5.15 (2.23) 4.93 (1.59) .173
LDL/HDL

PrimeTime 4.33 (1.76) 3.28 (1.18) 3.76 (1.54) 3.03 (1.17) .490
Ornish 4.18 (1.53) 3.59 (1.37) 2.89 (1.92) 3.33 (1.42) .035
Blood pressure (mm/Hg)

Systolic

PrimeTime 142 (21) 145 (21) 145 (20) 151 (23) .289
Ornish 134 (13) 140 (26) 127 (13) 131 (20) .755
Diastolic

PrimeTime 70 (10) 72 (7) 68 (13) 71 (10) .328
Ornisb 83 (8) 82 (13) 79 (7) 77 (11) .899
Weight (kg)

PrimeTime 80.3 (9.6) 79.3 (15.0) 76.4 (7.6) 79.24 (16.3) .045
Ornish 91.1 (15.5) 80.4 (22.8) 81.0 (11.4) 81.8 (25.0) .0001
Angina symptoms

Chest pain frequency

PrimeTime 2.40 (3.5) 2.80 (3.23) 0.50 (1.09) .90 (1.10) .099
Ornish 5.10 (14.1) 2.35 (3.77) 0.45 (0.76) 6.24 (12.9) .058
Chest pain duration

PrimeTime 9.57 (10.44) 6.20 (2.74) 3.14 (4.72) 6.70 (6.65) .094
Ornish 2.73 (4.69) 3.47 (7.95) 1.58 (4.48) 6.97 (14.5) .139
Chest pain severity

PrimeTime .79 (1.58) 1.60 (1.65) 1.50 (1.65) 2.30 (2.10) .184
Ornish 2.30 (1.60) 1.80 (1.10) 1.70 (1.20) 2.50 (1.20) .001

       - Significance of one-tailed multivariate analysis of covariance (MANCOVA) comparing the 12-month PrimeTime and Usual Care follow-up scores,
controlling for baseline scores. P values from Ornish Lifestyle Heart Trial (24) are two-tailed.

** To convert values for cholesterol to millimoles per liter, multiply by 0.02586; for triglycerides, multiply by .01129.

likely than men to report close adherence to prescription for lesterolemia. Still, selection bias is a major threat to external
exercise (22). validity. Investigators whenever possible should use recruitment

An important limitation of this study is the small sample of strategies that provide samples reflecting general population
motivated women and generalizability of results to all CHD characteristics. This was unfortunately not possible in the current
women over 50. It is possible that we have recruited a sample of investigation. A larger sample (at least 200, including adequate
highly motivated CHD women and that using a population-based numbers of minority participants) would have permitted a better
approach to recruitment would have produced a different set of demonstration of the feasibility of implementing this program with
results. However, other investigators have used similar recruitment larger, more diverse, and possibly less-motivated populations.
techniques in several major CHD clinical trials, including the The goals of this research and that of Omish et al. (24,25)
Multiple Risk Factor Intervention Trial (Mr. FIT) (44), a CHD diet differed. The major goal of the Lifestyle Heart Trial was to
and lifestyle trial conducted by Singh et ai. (10), and the large determine whether a comprehensive lifestyle program could by
Diabetes Control and Complications Trial (45). Other CHD itself reverse heart disease, which it did in mostly male study
behavioral investigations have experienced higher rates of nonpar- participants. The main goal of the present project was to test
ticipation than in our study, including the Take Pride project (22) whether the same procedures would produce substantial reductions


-----

were a surprising number of significant physiologic and quality of weeks on the Indian Diet Heart Study. American Journal of
life benefits accruing to the PrimeTime women. Overall lifestyle _Cardiology._ 1993, 71:1283-1288.
change appeared to have beneficial effects on general health, social (11) Warner JG, Brubaker PH, Zhu Y, et al: Long-term (5 year) changes in

HDL cholesterol in cardiac rehabilitation patients: Do sex differ-

functioning, and role functioning in women with CHD as mea-

ences exist? Circulation. 1995, 92:773-777.

sured by the SF-36. Our past experience with the SF-36 indicated

(12) Barnard RJ: Effects of life-style modification on serum lipids.

that this measure has been relatively resistant to change (47). The

_Archives of Internal Medicine._ 1991, 151:1389-1394.

results showing improvement in quality of life for PrimeTime

(13) Ornish D: Dr. Dean Ornish's Program for Reversing Heart Disease.

participants are particularly strong. The extent to which results

New York: Ballantine Books, 1990, 1-601.

obtained may apply to changes in coronary lesions is not known. (14) Allison M: A woman's heart. Harvard Health Letter. 1992, 17(6):

Future research, with larger sample sizes and more sensitive 5-7.
measures, is needed to more thoroughly investigate lipid and blood (15) Kannel WB: Contribution of the Framingham Study to preventive
pressure changes. The lipid measures were only collected once at cardiology. Journal of the American College of Cardiology. 1990,
each assessment point, which considerably inflates the error /5(1):206-211.
variance compared to the average of two or three measurements (16) Hjermann I, Holme I, Byre KV, Leren P: The effect of diet and

smoking intervention on the incidence of coronary heart disease.

used in most lipid reduction studies (21,41).

_Lancet._ 1981, 2:1303-1310.

Intensive, concurrent management of multiple lifestyle behav-

(17) Gordon NF, Scott CB, Levine BD: Comparison of single versus

iors may not seem feasible given the resources of many health care

multiple lifestyle interventions: Are the antihypertensive effects of

systems. The women who participated in this trial were at

exercise training and diet-induced weight loss additive? American

extremely high risk for further CHD-related diseases, which are

_Journal of Cardiology._ 1997, 79:763-767.

major causes of health care expenditures as well as mortality. For (18) National Institutes of Health: Innovative Approaches to Disease
them, a program with this level of intensity may be warranted. _Prevention Through Behavior Change,_ NIH Guide 26(36), RFA:
Still, the overall cost of the intervention is considerably less than OD-98-002(32). Washington, DC: U.S. Government Printing Office,
invasive surgical or even some intensive pharmacologic or cardiac 1997.
rehabilitation interventions (7). Future research should address (19) Omish D, Gotto Jr. AM, Miller RR, Rochelle D, McAllister G:
ways to reduce and more thoroughly evaluate costs of this Effects of a vegetarian diet and selected yoga techniques in the
intervention approach. It is possible that less frequent meetings and treatment of coronary heart disease [Abstract]. Clinical Research.

1979, 27:720A.

lay/peer led groups would be as effective (48,49). It may be that

(20) Ornish D, Scherwitz LW, Doody RS, et al: Effects of stress

some of the intervention components are less essential than others.

management training and dietary changes in treating ischemic heart

Our clinical impression is that the social support component is as

disease. Journal of the American Medical Association. 1983, 249:54-

critical for women with CHD as it appears to be in managing other

59.

diseases (50,51). More research is also needed to understand how

(21) Haskell WL, Alderman EL, Fair JM, et al: Effects of intensive

comprehensive lifestyle change affects quality of life, which may multiple risk factor reduction on coronary atherosclerosis and
be the ultimate outcome (52,53). Results of the current study are clinical cardiac events in men and women with coronary artery
encouraging. disease: The Stanford Coronary Risk Intervention Project (SCRIP).

_Circulation._ 1994, 89:975-990.
(22) Clark NM, Janz NK, Becker MH, et ah Impact of self-management

**REFERENCES** education on the functional health status of older adults with heart

(1) Khaw K: Epidemiology of coronary heart disease in women. In disease. Gerontologist. 1992, 32:438-443.

Julian D, Wenger NK (eds), Women and Heart Disease. London: (23) Toobert DJ, Glasgow RE, Nettekoven L, Brown JE: Behavioral and
Martin Dunitz Ltd., 1997. psychosocial effects of intensive lifestyle management for women
(2) Wenger NK, Speroff L, Packard B: Cardiovascular health and with coronary heart disease. _Patient Education and Counseling._

disease in women. _New England Journal of Medicine._ 1993, 1998, 35:177-188.
_329:247-256._ (24) Ornish D, Brown SE, Scherwitz LW, et al: Can lifestyle changes
(3) Wing RR, Epstein LH, Nowalk MP, Scott NG: Family history of reverse coronary heart disease? The Lifestyle Heart Trial. Lancet.

diabetes and its effect on treatment outcome in type H diabetes. 1990, 336:129-133.
_Behavior Therapy. 1987, 18:283-289._ (25) Ornish D, Scherwitz LW, Billings JH, et al: Intensive lifestyle
(4) Sharpe PA, Clark NM, Janz NK: Differences in impact and changes for reversal of coronary heart disease. _Journal of the_

management of heart disease between older women and men. _American MedicaI Association._ 1998, 280(23):2001-2007.

_Women's Health. 1991, 17:25-43._ (26) Kristal AR, Shattuck AL, Henry HJ: Patterns of dietary behavior
(5) Toobert DJ, Strycker LA, Glasgow RE: Lifestyle change in women associated with selecting diets low in fat: Reliability and validity of a

with coronary heart disease: What do we know? Journal of Women's behavioral approach to dietary assessment. Journal of the American
_Health._ 1998, 7:685-699. _Dietetic Association._ 1990, 90:214-220.
(6) Cowley MJ, Mullin SM, Kelsey SE et al: Sex differences in early- (27) Howat PM, Mohan R, Champagne C, et al: Validity and reliability of

and long-term results of coronary angioplasty in the NHLBI PTCA reported dietary intake data. Journal of the American Dietetic
Registry. Circulation. 1985, 71:90-97. _Association._ 1994, 94:169-173.
(7) Anderson GM, Pulcins IR: Recent trends in acute care hospital (28) Block G, Clifford C, Naughton MD, Henderson M, McAdams M: A

utilization in Ontario for diseases of the circulatory system. Cana- brief dietary screen for high fat intake. _Journal of Nutrition_
_dian MedicaI Association Journal._ 1991, 145:221-226. _Education._ 1989, 21:199-207.
(8) Eaker E, Chesebro JH, Sacks FM, et al: Special report: Cardiovascu- (29) Nutrition Coordinating Center: Minnesota Nutrition Data System

lar disease in women. Heart Disease and Stroke. 1994, 3:114-119. (NDS) Software. Minneapolis, MN: University of Minnesota, 1992.
(9) Perkins J, Dick TBS: Smoking and myocardial infarction: Secondary (30) King AC, Taylor CB, Haskell WL, DeBusk RF: Identifying strate-

prevention. Postgraduate Medicine. 1985, 61:295-300. gies for increasing employee physical activity levels: Findings from
(10) Singh RB, Singh NK, Rastogi SS, Mani UV, Niaz MA: Effects of the Stanford/Lockheed exercise survey. Health Education Quarterly.


-----

(31) Toobert DJ, Glasgow RE: Assessing diabetes self-management: The (43) Ades PA, Waldmann ML, Polk DM, Coflesky JT: Referral patterns

summary of diabetes self-care activities questionnaire. In Bradley C and exercise response in the rehabilitation of female coronary
(ed), Handbook of Psychology and Diabetes Research and Practice. patients aged greater than 62 years. American Journal of Cardiology.
Reading, UK: Harwood Academic, 1994, 351-375. 1992, 69:1422-1426.
(32) Research Consortium from Arizona State University: _Heritage_ (44) Multiple Risk Factor Intervention Trial Research Group: Multiple

_Manual of Procedures: Blood Pressure Measurements, Unit 3.5._ Risk Factor Intervention Trial. _Journal of the American Medical_

1993. _Association._ 1982, 248:1465-1477.
(33) Rose GA: The diagnosis of ischaemic heart pain and intermittent (45) DCCT Research Group: Lifetime benefits and costs of intensive

claudication in field surveys. Bulletin of the World Health Organiza- therapy as practiced in the Diabetes Control and Complications Trial.
_tion._ 1962, 27:645-658. _Journal of the American Medical Association._ 1996, _276:1409-_
(34) Anderson KM, Wilson PWE Odell PM, Kannel WB: An updated 1415.

coronary risk profile: A statement for health professionals. _Circula-_ (46) Kane JP, Malloy MJ, Ports TA, et al: Regression of coronary
_tion._ 1991, 83(1):356-362. atherosclerosis during treatment of familial hypercholesterolemia
(35) Ware JE, Sherbourne CD: The MOS 36-Item Short-Form Health with combined drug regimens. _Journal of the American Medical_

Survey (SF-36): I. Conceptual framework and item selection. _Association._ 1990, 264:3007-3012.
_Medical Care. 1992, 30:473-483._ (47) Glasgow RE, Toobert DJ, Hampson SE: Effects of a brief office-
(36) Paulhus DL: Two component models of social desirable responding. based intervention to facilitate diabetes dietary self-management.

_Journal of Personality and Social Psychology. 1984, 46:598-609._ _Diabetes Care. 1996,_ _19:835-842._
(37) Watts GF, Lewis B, Brunt JNH, et al: Effects on coronary artery (48) Lorig KR, Mazonson PD, Holman HR: Evidence suggesting that

disease of lipid-lowering diet, or diet plus cholestyramine, in the St. health education for self-management in patients with chronic
Thomas' Atherosclerosis Regression Study (STARS). Lancet. 1992, arthritis has sustained health benefits while reducing health care
_339:563-569._ costs. Arthritis and Rheumatism. 1993, 36:439-446.
(38) Schuler G, Hambrecht R, Schlierf G, et al: Regular physical exercise (49) Lorig K, Lubeck D, Kraines RG, Seleznick M, Holman HR:

and low-fat diet: Effects on progression of coronary heart disease. Outcomes of self-help education for patients with arthritis. _Arthritis_
_Circulation._ 1992, 86:1-11. _and Rheumatism._ 1985, 28:680~85.
(39) Arntzenius AC, Kromhout D, Barth JD, et al: Diet, lipoproteins, and (50) Spiegel D, Bloom JR, Kraemer HC, Gottheil E: Effects of psychoso-

the progression of coronary artherosclerosis. The Leiden Interven- cial treatment on survival of patients with metastatic breast cancer.
tion Trial. New England Journal of Medicine. 1985, 312:805-811. _Lancet._ 1989, 2(8668):888-891.
(40) de Lorgeril M, Renaud S, Mamelle N, et al: Mediterranean alph- (51) Glasgow RE, Toobert DJ: Social environment and regimen adher-

linolenic acid-rich diet in secondary prevention of coronary heart ence among type II diabetic patients. _Diabetes Care. 1988,_ _11:377-_
disease. Lancet. 1994, 343:1454-1459. 386.
(41) Sacks FM, Pfeffer MA, Moye LA, et al: The effect of Pravastatin on (52) Kaplan RM, Bush JW: Health-related quality of life measurement

coronary events after myocardial infarction in patients with average for evaluation research and policy analysis. _Health Psychology._
cholesterol levels. New England Journal of Medicine. 1996, 35:1001- 1982, 1(1):61-80.

1009. (53) Oldridge N, Guyatt G, Jones N, et al: Effects on quality of life with
(42) Boogaard M: Rehabilitation of the female patient after myocardial comprehensive rehabilitation after acute myocardial infarction.

infarction. Nursing Clinics of North America. 1984, 19:443-449. _American Journal of Cardiology._ 1991, _67:1084-1089._


-----

